Trial intelligence / Profile preview

Intraoperative nimodipine application during vestibular schwannoma resection

2020-005215-46Phase 3Completed

Sponsor
Medical University of Vienna
Start
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in acoustic neuroma, facial palsy and sensorineural hearing loss (SNHL) comparing Nimodipine arm with Placebo arm (2 arms). Primary endpoint: Gardner-Robertson Scale. Started Nov 2020; status: completed.

02

Drugs

nimodipine
03

Conditions

acoustic neuromafacial palsysensorineural hearing loss (SNHL)

Beyond the preview

Go deeper on 2020-005215-46.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-005215-46.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call